Search

everythinglearnresearchcommunity

for

Search:↓

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Hair follicles prevent NK cell attacks to avoid hair loss.

Skin-derived stem cells grow faster and are easier to obtain than hair follicle stem cells, but both can become various cell types.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

SM04554 may increase hair growth as a topical treatment for androgenetic alopecia.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Fisetin may help treat psoriasis and reduce skin inflammation.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Skin cells produce and activate vitamin D, which regulates skin functions and supports hair growth.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

Macrophages are vital for skin healing, hair growth, salt balance, and cancer defense.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Alefacept showed some effectiveness for alopecia areata but needs more research.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.